TheraSense Freestyle Navigator

Continuous interstitial fluid glucose monitor PMA submission announced Dec. 2 seeks labeling to allow use "instead of" traditional in vitro testing, the firm says. FDA panel review likely will be required, according to the company (1"The Gray Sheet" Sept. 15, 2003, p. 18)...